Home > Insider Trading > Filing (0001651308-25-000101)

Filing Details

Accession Number:: 0001651308-25-000101
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-10 16:55:12
Reporting Period:: 2025-06-06

Filing Date:: 2025-06-10
Accepted Time:: 2025-06-10 16:55:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651308	Beone Medicines Ltd.	ONC	Pharmaceutical Preparations (2834)	981209416

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1739452	Xiaobin Wu	C/O Beone Medicines I Gmbh Aeschengraben 27, 21St Floor Basel V8 4051	President And Coo	No	Yes	No	No

Transaction Summary

Sold:	1,934 shares	Avg. Price: $253.15	Total Value: $489,591.02

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
American Depositary Shares	Disposition	2025-06-06	400	$250.74	1,534	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-06	500	$251.85	1,034	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-06	400	$253.50	634	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-06	400	$255.31	234	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-06	234	$255.77	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	1,150,926	Direct
American Depositary Shares	12,365	Direct
American Depositary Shares	4,000	Indirect	By Wife

Footnotes

Each American Depositary Share represents 13 Ordinary Shares.
The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.56 to $251.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.585 to $252.14, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.31 to $253.81, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.60 to $255.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.67 to $255.8887, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.